AIT India 2024/25: Bilal Fares, Co-Founder and CEO of Azure Cell Therapies (Switzerland)

Ansichten Kommentare

In this video, Bilal Fares, Co-Founder and CEO of Azure Cell Therapies, talks about his participation in the 2024/25 edition of the Academia-Industry Training (AIT) India program. Find out more on our website.